DE196932T1 - Nichtabsorbierbares arzneimittel in magensaftloeslicher und magensaftresistenter form. - Google Patents
Nichtabsorbierbares arzneimittel in magensaftloeslicher und magensaftresistenter form.Info
- Publication number
- DE196932T1 DE196932T1 DE1986400317 DE86400317T DE196932T1 DE 196932 T1 DE196932 T1 DE 196932T1 DE 1986400317 DE1986400317 DE 1986400317 DE 86400317 T DE86400317 T DE 86400317T DE 196932 T1 DE196932 T1 DE 196932T1
- Authority
- DE
- Germany
- Prior art keywords
- lubricant
- resistant form
- stomach
- absorbable
- resistant
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 239000000314 lubricant Substances 0.000 title 1
- 239000003814 drug Substances 0.000 claims 2
- 210000002784 stomach Anatomy 0.000 claims 2
- 230000002496 gastric effect Effects 0.000 claims 1
- 210000001035 gastrointestinal tract Anatomy 0.000 claims 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/74—Synthetic polymeric materials
- A61K31/80—Polymers containing hetero atoms not provided for in groups A61K31/755 - A61K31/795
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
- A61K9/5084—Mixtures of one or more drugs in different galenical forms, at least one of which being granules, microcapsules or (coated) microparticles according to A61K9/16 or A61K9/50, e.g. for obtaining a specific release pattern or for combining different drugs
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Medicinal Preparation (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Claims (2)
1. Gastro-intestinales Medikament, das nicht absorbierbar, aber löslich ist
und für die Behandlung beider Bereiche des Verdauungstraktes bestimmt
ist, dadurch gekennzeichnet, daß es eine galenisch-pharmazeutische
Form aufweist, die magenresistent ist und der eine galenisch-pharmazeutische Form zugeordnet ist, die magenlöslich ist.
Form aufweist, die magenresistent ist und der eine galenisch-pharmazeutische Form zugeordnet ist, die magenlöslich ist.
2. Medikament nach Anspruch 1, dadurch gekennzeichnet, daß es zwingend
die magenlösliche und die magenresistente Form aufweist.
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
FR8502623A FR2577800B1 (fr) | 1985-02-22 | 1985-02-22 | Medicament sous forme galenique gastro-resistante |
Publications (1)
Publication Number | Publication Date |
---|---|
DE196932T1 true DE196932T1 (de) | 1987-03-19 |
Family
ID=9316555
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DE1986400317 Pending DE196932T1 (de) | 1985-02-22 | 1986-02-14 | Nichtabsorbierbares arzneimittel in magensaftloeslicher und magensaftresistenter form. |
Country Status (5)
Country | Link |
---|---|
EP (1) | EP0196932A1 (de) |
JP (1) | JPS62123111A (de) |
DE (1) | DE196932T1 (de) |
FR (1) | FR2577800B1 (de) |
IL (1) | IL77930A (de) |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1097456C (zh) * | 1997-12-22 | 2003-01-01 | 永信药品工业股份有限公司 | 胃肠消泡锭剂的制造方法及其应用 |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
AU407324B2 (en) * | 1962-05-01 | 1970-10-28 | Smith, Kline & French Laboratories | Powdered silicone products and processes |
JPS52139713A (en) * | 1976-05-13 | 1977-11-21 | Shionogi & Co Ltd | Sustained release cefalexin preparations |
FR2390953A1 (fr) * | 1977-05-20 | 1978-12-15 | Grimberg Georges | Medicament a base de charbon |
-
1985
- 1985-02-22 FR FR8502623A patent/FR2577800B1/fr not_active Expired - Lifetime
-
1986
- 1986-02-14 EP EP86400317A patent/EP0196932A1/de not_active Withdrawn
- 1986-02-14 DE DE1986400317 patent/DE196932T1/de active Pending
- 1986-02-19 IL IL7793086A patent/IL77930A/xx not_active IP Right Cessation
- 1986-02-21 JP JP3714886A patent/JPS62123111A/ja active Pending
Also Published As
Publication number | Publication date |
---|---|
IL77930A (en) | 1992-03-29 |
FR2577800B1 (fr) | 1990-09-07 |
EP0196932A1 (de) | 1986-10-08 |
JPS62123111A (ja) | 1987-06-04 |
FR2577800A1 (fr) | 1986-08-29 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Malec et al. | Video game practice effects on sustained attention in patients with craniocerebral trauma. | |
CA2061917A1 (en) | Pediatric effervescent dosage form | |
DE69021214D1 (de) | Orale zusammensetzung für die behandlung intestinaler entzündlicher krankheiten. | |
IL94267A0 (en) | Compositions for treating skin disorders containing ketoconazole and their preparation | |
DE3382641D1 (de) | Arzneimittel fuer die therapeutische behandlung von alopezie. | |
ATE82118T1 (de) | Feste und poroese einheitsform, enthaltend mikropartikel und/oder nanopartikel und verfahren zu ihrer herstellung. | |
CA2164229A1 (en) | Skin treatment method utilizing an alpha-hydroxy acid composition and an applicator pad | |
CA2071215A1 (en) | Method and composition for treating inflammatory bowel disorders | |
TW197423B (de) | ||
CA2035951A1 (en) | Bilobalide derivatives, their applications and formulations containing them | |
DE196932T1 (de) | Nichtabsorbierbares arzneimittel in magensaftloeslicher und magensaftresistenter form. | |
IE38655L (en) | Pharmaceutical compositions | |
ATE152350T1 (de) | Pharmazeutische zusammensetzungen die 5- difluormethoxy-2-(3,4-dimethoxy-2- pyridyl)methylsulfinyl>-1h-benzimidazol und ein anti-heliobactermittel enthalten zur behandlung von magen-darm krankheiten | |
Rosen et al. | Clinical trial of carbidopa-{l}-dopa combination for cocaine abuse. | |
EP0279867A3 (de) | Verwendung von Vitamin-E und Vitamin-E-Kombination mit nichtsteroidalen Antirheumatika und Schmerzmittel zur Behandlung von rheumatischen Erkrankungen | |
EG17992A (en) | Preparation of a medicament for arthritis and theumatism | |
DE345883T1 (de) | Verwendung von dapiprazol zur herstellung eines arzneimittels zur verhinderung des toleranzentwicklung bei der analgetischen behandlung mit morphin. | |
DE3681289D1 (de) | Zusammensetzung fuer die bereitung eines arzneimittels zur topischen behandlung paradentaler krankheiten. | |
WO1986006960A3 (en) | Use of nicorandil or pinacidil for the treatment of peripheral vascular disease | |
FR2355508B1 (fr) | Medicament destine a la prevention et au traitement des caries dentaires et des parodontopathies et son procede de preparation | |
Zung | The effect of placebo and drugs on human sleep. | |
Sowton et al. | Clinical assessment of “Etrynit” for angina pectoris | |
EP0327040A3 (de) | Verwendung von Dopamin und/oder von Dopamin-Agonisten zur Herstellung eines Arzneimittels für die Behandlung des Verdauungstrakts | |
PH24028A (en) | The use of anipamil in the treatment of arteriosclerosis | |
Češková et al. | Alternative therapeutic approaches to the treatment of acute phases of endogenous psychoses. |